Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
* To assess safety of Dietressa in the dose of 6 tablets daily within 24 weeks in treatment of obese patients (BMI 35,0-39,9 kg/m2). * To assess clinical efficacy of Dietressa in the dose of 6 tablets daily after 24 weeks of therapy in reducing body weight in obese patients (BMI 35,0-39,9 kg/m2).
Epistemonikos ID: f064915bdc17af705393ef8ff0ba67a074c7ad9d
First added on: May 10, 2024